Evaluating Patients With Abnormal Levels of Gastric Acid

Diagnostic Evaluation of Patients With Suspected Abnormalities of Gastric Secretion

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00001240

Enrollment

Unknown

Registered

1999-11-04

Start date

1989-01-31

Completion date

2004-01-31

Last updated

2008-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achlorhydria, Gastrinoma, Zollinger Ellison Syndrome

Keywords

Stomach, Hypersecretion, Hyposecretion, Gastrinoma, Zollinger-Ellison Syndrome

Brief summary

This study is used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities in the secretion of gastric acid. The level of gastric acid is measured by analyzing the gastric juices of each individual patient. The gastric acid sample is obtained by a procedure known as nasogastric suctioning, where a thin plastic tube is passed from the nose to the stomach. Depending on the patient's present condition further diagnostic testing may be required to achieve a diagnosis.

Detailed description

This study is an omnibus protocol used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities of gastric acid secretion. Gastric acid secretion is measured by means of analysis of gastric juices obtained by nasogastric suction. Other clinically indicated diagnostic procedures are performed depending on the patient's clinical state in order to reach a diagnosis.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Eligibility criteria not identified in the protocol.

Countries

United States

Outcome results